Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway

BACKGROUND: Parecoxib plays an important role in inhibition of human cancer. However, the effect of parecoxib on esophageal squamous cell carcinoma (ESCC) is still not well known. The purpose of this study was to investigate the effect of parecoxib on ESCC and its underlying mechanism. METHODS: RNA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Han-Ming, Huang, Xiao-Yu, Wu, Shao-Ping, Chen, Can-Keng, He, Xin-Hua, Zhang, Yong-Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933956/
https://www.ncbi.nlm.nih.gov/pubmed/35305553
http://dx.doi.org/10.1186/s11658-022-00324-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933956/
https://www.ncbi.nlm.nih.gov/pubmed/35305553
http://dx.doi.org/10.1186/s11658-022-00324-w

Ejemplares similares